Validation of COPD population screener (COPD-PS) questionnaire in a community-based setting of Nepal

01 May 2022
Background Chronic obstructive pulmonary disease (COPD) is a common chronic condition characterized by progressive airflow obstruction that is not fully reversible. Despite being a treatable and preventable condition, COPD remains largely undiagnosed and untreated in low- and middle-income countries like Nepal. This study aims to assess the validity of the COPD population screener (COPD-PS) questionnaire in a community-based intervention in Nepal.MethodsA household survey was conducted among 1438 randomly selected individuals in a semiurban area of Pokhara Metropolitan City of Western Nepal. Participants were interviewed with a survey questionnaire, including COPD-PS. Trained enumerators conducted spirometry using a portable spirometer for the detection of COPD defined by fixed ratio (FR) criteria (FEV1/FVC<0.70 and symptoms) and lower limit of normal (LLN) criteria (FEV1/FVC<LLN and symptoms).ResultsThe prevalence of COPD was 8.5% (FR) and 5.4% (LLN). The ability of COPD-PS to discriminate individuals with and without COPD was good irrespective of COPD definition. The overall area under the receiver operating characteristic curve was 0.860 (LLN) and 0.857 (FR). COPD-PS cut-off point of 4 resulted in sensitivity, specificity, positive predictive value, and negative predictive values of 84.4%, 73.5%, 15.3%, and 98.8%, respectively, according to LLN criteria and 82.8%, 75.3%, 23.7%, and 97.9%, respectively, according to FR criteria.Conclusion: This five-item easy-to-use COPD-PS questionnaire can be used in the screening of COPD in Nepal. Declaration of Interest None References and Clinical Trial Registry Information

Resource information

Type of resource
Abstract
Conference
Dublin 2021
Author(s)
Tara Ballav Adhikari